The Motley Fool Podcasts Industry Focus Healthcare: How Marijuana Legalization Impacted OrganiGram and Aphria's Latest Results

Healthcare:  How Marijuana Legalization Impacted OrganiGram and Aphria's Latest Results Logo

Healthcare: How Marijuana Legalization Impacted OrganiGram and Aphria's Latest Results

Marijuana stocks OrganiGram and Aphria reported quarterly earnings this week - here's what you should know. Also, Abbott locks horns with DexCom in diabetes and what's next for Bristol-Myers' now that its Celgene acquisition is official.

Check out more of our content here:

Listen to Healthcare: How Marijuana Legalization Impacted OrganiGram and Aphria's Latest Results

Recent Episodes

Listen
Listen
Listen
Listen
Listen
Listen
Listen
Listen
Listen
Listen

More Podcasts